This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Harris Williams & Co. Advises Milliman Care Guidelines LLC In Its Sale To Strategic Buyer Hearst Corporation

Harris Williams & Co., a preeminent middle market investment bank focused on the advisory needs of clients worldwide, announces the sale of Milliman Care Guidelines LLC (Care Guidelines), a leading provider of evidence-based clinical decision support software solutions to the healthcare industry, to Hearst Corporation (Hearst). Harris Williams & Co. acted as the exclusive financial advisor to Care Guidelines. The transaction closed on December 3, 2012, and was led by Jeff Bistrong, Sam Hendler and Kojo Appenteng from the firm’s Technology, Media & Telecom (TMT) Group in Boston and Todd Morris and Andy Dixon from the firm’s Healthcare & Life Sciences (HCLS) Group in San Francisco.

“The acquisition of Care Guidelines by Hearst illustrates the strong, continued demand from large diversified technology and media companies for leading edge HCIT businesses, particularly those with differentiated content and SaaS delivery solutions,” said Jeff Bistrong, managing director at Harris Williams & Co.

“Care Guidelines’ solutions are a key enabler of the transition from fee-for-service to fee-for-value taking place within healthcare,” said Sam Hendler, a director in Harris Williams & Co.’s TMT Group who leads the firm’s HCIT practice. “These are fundamental software tools for both payers and providers as they navigate the ongoing transformation of the healthcare ecosystem and the expansion of Accountable Care Organizations (ACOs).”

Care Guidelines, based in Seattle, WA, is a wholly-owned subsidiary of Milliman Inc. The company is the leading provider of evidence-based clinical guidelines and software that deliver the most efficient and effective plan of care for patients in need of healthcare treatment. The company’s platform, used by more than 1,900 clients, including more than 1,200 provider organizations and seven of the eight largest U.S. health plans, provides decision support to help payors and providers manage risk and deliver high quality care at the lowest possible cost.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,084.49 +33.74 0.20%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,830.47 +19.6820 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs